Dexcom Inc
(DXCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,835,700 | 1,159,000 | 904,900 | 606,100 | 621,200 |
| Marketable Securities | 1,486,400 | 1,770,300 | 1,796,500 | 1,973,300 | 1,871,100 |
| Receivables | 1,109,600 | 1,348,800 | 1,155,200 | 1,005,700 | 1,002,000 |
| Inventories | 604,100 | 570,700 | 538,200 | 542,600 | 586,300 |
| TOTAL | $5,219,500 | $5,030,200 | $4,553,800 | $4,301,400 | $4,262,800 |
| Non-Current Assets | |||||
| PPE Net | 1,471,300 | 1,457,300 | 1,364,700 | 1,339,900 | 1,318,800 |
| Intangibles | 103,100 | 111,300 | 118,300 | 126,200 | 130,000 |
| Other Non-Current Assets | 706,100 | 728,200 | 714,900 | 717,000 | 642,200 |
| TOTAL | $2,280,500 | $2,296,800 | $2,197,900 | $2,183,100 | $2,091,000 |
| Total Assets | $7,500,000 | $7,327,000 | $6,751,700 | $6,484,500 | $6,353,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,932,400 | 1,943,800 | 1,690,600 | 1,585,100 | 1,592,500 |
| Accrued Expenses | 170,200 | 129,300 | 110,800 | 112,000 | 105,800 |
| TOTAL | $3,336,000 | $3,308,700 | $3,037,100 | $2,932,000 | $1,734,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,239,900 | 1,238,900 | 1,238,000 | 1,237,000 | 2,439,600 |
| Deferred Revenues | 2,900 | 6,100 | 7,800 | 8,000 | 13,900 |
| Other Non-Current Liabilities | 198,000 | 206,300 | 210,000 | 212,900 | 200,700 |
| TOTAL | $1,437,900 | $1,445,200 | $1,448,000 | $1,449,900 | $2,640,300 |
| Total Liabilities | $4,773,900 | $4,753,900 | $4,485,100 | $4,381,900 | $4,374,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 390,016 | 392,155 | 392,108 | 390,772 | 390,595 |
| Common Shares | 400 | 400 | 400 | 400 | 400 |
| Retained earnings | 2,166,600 | 1,882,800 | 1,703,000 | 1,597,600 | 1,445,900 |
| Other shareholders' equity | 81,600 | 83,400 | 2,000 | -8,200 | 63,200 |
| TOTAL | $2,726,100 | $2,573,100 | $2,266,600 | $2,102,600 | $1,979,000 |
| Total Liabilities And Equity | $7,500,000 | $7,327,000 | $6,751,700 | $6,484,500 | $6,353,800 |